New oral anticoagulants

CMAJ. 2013 Mar 5;185(4):E212. doi: 10.1503/cmaj.120078. Epub 2012 Nov 12.
No abstract available

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications
  • Benzimidazoles / adverse effects
  • Benzimidazoles / therapeutic use*
  • Canada
  • Contraindications
  • Dabigatran
  • Drug Dosage Calculations
  • Drug Interactions
  • Humans
  • Morpholines / adverse effects
  • Morpholines / therapeutic use*
  • Postoperative Complications / prevention & control*
  • Pyridines / adverse effects
  • Pyridines / therapeutic use*
  • Rivaroxaban
  • Stroke / etiology
  • Stroke / prevention & control*
  • Thiophenes / adverse effects
  • Thiophenes / therapeutic use*
  • Venous Thromboembolism / etiology
  • Venous Thromboembolism / prevention & control*
  • Venous Thrombosis / drug therapy*

Substances

  • Anticoagulants
  • Benzimidazoles
  • Morpholines
  • Pyridines
  • Thiophenes
  • Rivaroxaban
  • Dabigatran